Study / year | Number of patients | Ventilation support | Final pathology diagnosis | Management changes | Complications | Survivals |
---|---|---|---|---|---|---|
Dincer et al./2018 | 5 | MV | 5/5 (2 DAD, 2 OP and 1 IPS) | 5/5 | None | 4/5 |
Cooley et al./2019 | 11 | MV | 9/11 (4DAD, 2COP and 3 others) | 8/11 | 4 pneumothorax, 2 persistent air leak, 1 significant bleeding | 6/11 |
Las Heras et al./2019 | 4 | MV | 4/4 (3 DAD and 1 other) | 2/4 | None | NA |
Current study | 5 | MV and ECMO | 5/5 (2 DAD and 3 others) | 5/5 | 2 significant bleeding | 3/5 |
Summary | 25 | – | 23/25 (11/25 DAD) | 20/25 | 4/25 pneumothorax, 3/25 significant bleeding, 2/25 persistent air leak | 13/21 |